BRCA1/2-driven tumors usually arise via 2-hit mechanism: while the involved gene is present in heterozygous but still proficient state in the normal cells of the carrier, cancer cells are characterized by somatic loss of the remaining BRCA allele and therefore demonstrate deficiency in DNA repair by homologous recombination (HR). The gene discussed is BRCA1; the disease is cancer.